Coverage of high-potential mid-market firms in Poland

Article

Neuca pharma posts PLN 13.1 mln net profit in Q4 vs. PLN 15.5 mln profit expected

TAG'S: NEUCA, Finance (other)

 

Listed pharmaceuticals distributor Neuca posted PLN 13.1 mln Q4 attributable net profit, below expectations for PLN 15.5 mln net take, Neuca said in FY 2013 report.

 

Q4 RESULTS VS CONSENSUS & VS YEAR-PRIOR PERIOD

 

  Q3 2013 consensus Q3 y/y vs Cons.
  PLN mln PLN mln % %
Revenues 1409,7 1464 -3,2 -3,7
Operating profit 17,1 18 -20,6 -5,2
Net attributable 13,1 15,5 -11,4 -15,3

2014-03-18



Comments : 0

Add comment

The published comments are private opinions of the users. Biznespolska Media Sp. z o.o. is not responsible for their content. Intelligent and insightful comments most appreciated.

Other News

Photo of the week

Photo of the week

Following an impressive run, PKN Orlen fuel reappoints CEO Wojciech Jasiński to spearhead the company to newer, more challenging waters. Gives him a new three year term!

2018-02-19

WSE Indices


NameValueChangeTime
WIG20 2403,11 -0,16 % 16:07
WIG 62703,88 -0,18 % 16:07
sWIG80 14769,32 +0,09 % 16:07
NCIndex 269,69 -0,42 % 16:05
2018-02-19

WSE Companies


Top 5 Gainers

NameValueChange
KERDOS GROUP0,02+100,00 %
FAM1,80+11,11 %
REMAK11,75+8,29 %
PBS FINANSE0,75+8,70 %
PEIXIN INTERNATIONAL2,00+8,11 %

Top 5 Losers

NameValueChange
PRIMA MODA3,87-19,37 %
KORPORACJA BUDOWLANA DOM2,32-15,94 %
IQ PARTNERS0,47-7,84 %
KRAKCHEMIA1,69-7,65 %
KSG AGRO1,68-6,15 %